Literature DB >> 23146697

Answers to critics: Why there is a long term toxicity due to a Roundup-tolerant genetically modified maize and to a Roundup herbicide.

Gilles-Eric Séralini, Robin Mesnage, Nicolas Defarge, Steeve Gress, Didier Hennequin, Emilie Clair, Manuela Malatesta, Joël Spiroux de Vendômois.   

Abstract

Our recent work (Séralini et al., 2012) remains to date the most detailed study involving the life-long consumption of an agricultural genetically modified organism (GMO). This is true especially for NK603 maize for which only a 90-day test for commercial release was previously conducted using the same rat strain (Hammond et al., 2004). It is also the first long term detailed research on mammals exposed to a highly diluted pesticide in its total formulation with adjuvants. This may explain why 75% of our first criticisms arising within a week, among publishing authors, come from plant biologists, some developing patents on GMOs, even if it was a toxicological paper on mammals, and from Monsanto Company who owns both the NK603 GM maize and Roundup herbicide (R). Our study has limits like any one, and here we carefully answer to all criticisms from agencies, consultants and scientists, that were sent to the Editor or to ourselves. At this level, a full debate is biased if the toxicity tests on mammals of NK603 and R obtained by Monsanto Company remain confidential and thus unavailable in an electronic format for the whole scientific community to conduct independent scrutiny of the raw data. In our article, the conclusions of long-term NK603 and Roundup toxicities came from the statistically highly discriminant findings at the biochemical level in treated groups in comparison to controls, because these findings do correspond in an blinded analysis to the pathologies observed in organs, that were in turn linked to the deaths by anatomopathologists. GM NK603 and R cannot be regarded as safe to date.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146697     DOI: 10.1016/j.fct.2012.11.007

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

Review 1.  EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.

Authors:  Yann Devos; Jaime Aguilera; Zoltán Diveki; Ana Gomes; Yi Liu; Claudia Paoletti; Patrick du Jardin; Lieve Herman; Joe N Perry; Elisabeth Waigmann
Journal:  Transgenic Res       Date:  2013-08-21       Impact factor: 2.788

2.  Retracting Inconclusive Research: Lessons from the Séralini GM Maize Feeding Study.

Authors:  David B Resnik
Journal:  J Agric Environ Ethics       Date:  2015-08       Impact factor: 1.727

3.  Major pesticides are more toxic to human cells than their declared active principles.

Authors:  Robin Mesnage; Nicolas Defarge; Joël Spiroux de Vendômois; Gilles-Eric Séralini
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

4.  Inconclusive findings: now you see them, now you don't!

Authors:  Christopher J Portier; Lynn R Goldman; Bernard D Goldstein
Journal:  Environ Health Perspect       Date:  2014-02       Impact factor: 9.031

5.  Advocacy Science: Explaining the Term with Case Studies from Biotechnology.

Authors:  Ksenia Gerasimova
Journal:  Sci Eng Ethics       Date:  2017-06-08       Impact factor: 3.525

6.  Strategic science translation in emerging science: genetically modified crops and Bisphenol A in two cases of contested animal toxicity studies.

Authors:  Monica Racovita; Armin Spök
Journal:  GM Crops Food       Date:  2022-12-31       Impact factor: 3.118

7.  Conflicts of interests, confidentiality and censorship in health risk assessment: the example of an herbicide and a GMO.

Authors:  Gilles-Eric Séralini; Robin Mesnage; Nicolas Defarge; Joël Spiroux de Vendômois
Journal:  Environ Sci Eur       Date:  2014-06-24       Impact factor: 5.893

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.